Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Assets Average: 2020-2025

Historic Assets Average for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $88.2 million.

  • Biodesix's Assets Average fell 19.27% to $88.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.2 million, marking a year-over-year decrease of 19.27%. This contributed to the annual value of $98.2 million for FY2024, which is 2.26% up from last year.
  • As of Q3 2025, Biodesix's Assets Average stood at $88.2 million, which was up 1.43% from $87.0 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Assets Average ranged from a high of $118.3 million in Q1 2021 and a low of $68.4 million during Q2 2022.
  • Over the past 3 years, Biodesix's median Assets Average value was $91.7 million (recorded in 2025), while the average stood at $92.0 million.
  • As far as peak fluctuations go, Biodesix's Assets Average slumped by 41.77% in 2022, and later soared by 32.95% in 2024.
  • Biodesix's Assets Average (Quarterly) stood at $83.0 million in 2021, then declined by 6.01% to $78.1 million in 2022, then rose by 19.08% to $92.9 million in 2023, then rose by 7.59% to $100.0 million in 2024, then dropped by 19.27% to $88.2 million in 2025.
  • Its Assets Average was $88.2 million in Q3 2025, compared to $87.0 million in Q2 2025 and $91.7 million in Q1 2025.